- Home
- TOPP vs UBX Comparison
TOPP vs UBX Comparison
Compare TOPP & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPP
- UBX
- Stock Information
- Founded
- TOPP 2014
- UBX 2009
- Country
- TOPP United States
- UBX United States
- Employees
- TOPP N/A
- UBX N/A
- Industry
- TOPP
- UBX Biotechnology: Pharmaceutical Preparations
- Sector
- TOPP
- UBX Health Care
- Exchange
- TOPP NYSE
- UBX Nasdaq
- Market Cap
- TOPP 23.1M
- UBX 16.2M
- IPO Year
- TOPP 2025
- UBX 2018
- Fundamental
- Price
- TOPP $1.50
- UBX $0.91
- Analyst Decision
- TOPP
- UBX Strong Buy
- Analyst Count
- TOPP 0
- UBX 3
- Target Price
- TOPP N/A
- UBX $5.33
- AVG Volume (30 Days)
- TOPP 151.4K
- UBX 108.0K
- Earning Date
- TOPP 01-01-0001
- UBX 04-22-2025
- Dividend Yield
- TOPP N/A
- UBX N/A
- EPS Growth
- TOPP N/A
- UBX N/A
- EPS
- TOPP 0.01
- UBX N/A
- Revenue
- TOPP $16,039,513.00
- UBX N/A
- Revenue This Year
- TOPP N/A
- UBX N/A
- Revenue Next Year
- TOPP N/A
- UBX N/A
- P/E Ratio
- TOPP $125.24
- UBX N/A
- Revenue Growth
- TOPP N/A
- UBX N/A
- 52 Week Low
- TOPP $0.97
- UBX $0.85
- 52 Week High
- TOPP $4.50
- UBX $3.10
- Technical
- Relative Strength Index (RSI)
- TOPP N/A
- UBX 37.30
- Support Level
- TOPP N/A
- UBX $0.86
- Resistance Level
- TOPP N/A
- UBX $1.23
- Average True Range (ATR)
- TOPP 0.00
- UBX 0.09
- MACD
- TOPP 0.00
- UBX 0.01
- Stochastic Oscillator
- TOPP 0.00
- UBX 13.49
About TOPP TOPPOINT HOLDINGS INC
Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain.
About UBX Unity Biotechnology Inc.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.